Home » Chinese Healthcare Investors »


|| Chinese firm acquired Canada Iovate Health for $730 million

china-canadaChinese firm Xiwang has acquired Canada's nutrition supplement maker Iovate Health for $730 million.

Founded in 1995 and based in Oakville, Canada with 330 employees, Iovate products are sold in more than 130 countries worldwide. Founded in 2007 based in Shandong Province, China with consolidated revenue in excess of $5 billion, Xiwang Food is a leading Chinese player in healthy consumable oils such as corn oil and flaxseed oil.

To see a list of investors from China similar to Xiwang, check the Chinese Investors Directory.

More details follows



Previous Post: China Ant Financial acquired US eye scan startup for $70 million
Next Post: Chinese investors of Shanhai Capital acquired US semiconductor firm for $500 million

More from Chinese Healthcare Investors ...


  Chinese firm invested $12 million in UK company Blueberry Therapeutics

  Chinese investors acquired SciClone Pharmaceuticals for $605 million

  Chinese firm acquired Canada Iovate Health for $730 million

  Chinese investors acquired Australian vitamin maker Vitaco for $239 million

  Chinese investors of ORI Capital invested $18 million in Boston firm Pillar Biosciences

  Chinese investors of Citic acquired stake at Singapore medical firm for $817 million

  Chinese Hepalink acquired US Cytovance Biologics for $205 million

  Chinese investors acquired stake at Israeli biotech firm for $3 million

  Chinese investors of LongTec invested $10 million in RealView Imaging

  Chinese Decheng Capital and consortium invested $120 million in California genetics firm





| About Us

Rubenstein
SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.



|Subscribe to mailing list

Enter your email address:



Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2022     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn